Over the past decades, lipid‐based nanoparticle drug delivery systems (DDS) have caught
the attention of researchers worldwide, encouraging the field to rapidly develop improved …

The bottom-up assembly of biological and chemical components opens exciting
opportunities to engineer artificial vesicular systems for applications with previously unmet …

β-Barrel outer membrane proteins (OMPs) represent the major proteinaceous component of
the outer membrane (OM) of Gram-negative bacteria. These proteins perform key roles in …

During endocytosis of nanoparticles by cells, the cellular membranes engulf the particles,
thereby forming a closed membrane neck that subsequently undergoes fission. For solid …

The plasma membrane phospholipid distribution of animal cells is markedly asymmetric.
Phosphatidylserine (PS) and phosphatidylethanolamine (PE) are concentrated in the inner …

The interaction of drugs with biological membranes is a critical factor affecting their
pharmacokinetics and pharmacodynamics, so understanding how drugs interact with …

Liposome-based drug delivery systems are nanosized spherical lipid bilayer carriers that
can encapsulate a broad range of small drug molecules (hydrophilic and hydrophobic …

Circulation lifetime is a crucial parameter for a successful therapy with nanoparticles.
Reduction and alteration of opsonization profiles by surface modification of nanoparticles is …

Conspectus The lipid bilayer, together with embedded proteins, is the central structure in
biomembranes. While artificial lipid bilayers are useful to model natural membranes, they …

Biological and biomimetic membranes are based on lipid bilayers, which consist of two
monolayers or leaflets. To avoid bilayer edges, which form when the hydrophobic core of …